Telehealth Insomnia Prescribing: What Psychiatrists Can Do in North Carolina

If you’re a psychiatrist or PMHNP considering telehealth, you’ve probably wondered: Can I actually prescribe sleep medications remotely? What about controlled substances like Ambien? Do I need to see the patient in person first?

Short answer: Yes, you can prescribe insomnia medications via telehealth right now — including Schedule IV controlled substances like zolpidem (Ambien), eszopiclone (Lunesta), and temazepam. Federal flexibilities currently allow tele-prescribing of controlled substances without an initial in-person visit through at least December 31, 2025 (likely to be extended or made permanent).

But here’s the catch: your ability to practice independently and prescribe these medications depends entirely on your state’s scope of practice laws — especially if you’re a PMHNP.

Let’s break down exactly what you can do, what you need to know, and how joining a telehealth platform like Klarity Health removes the headaches of patient acquisition while you focus on what you do best: clinical care.

The Current Telehealth Prescribing Landscape for Insomnia

Federal Rules: The DEA Extension Through 2025

During COVID-19, the DEA suspended the Ryan Haight Act requirement that providers conduct an in-person evaluation before prescribing controlled substances via telemedicine. That flexibility has been extended through December 31, 2025, meaning you can legally prescribe Schedule II-V controlled substances (including common insomnia meds) in a telehealth visit nationwide — no prior in-person visit required.

This is huge for insomnia treatment, because many effective sleep medications are Schedule IV controlled substances:

• Zolpidem (Ambien)
• Eszopiclone (Lunesta)
• Temazepam (Restoril)
• Zaleplon (Sonata)

You establish a patient-provider relationship via video consultation, conduct a thorough evaluation (sleep history, psychiatric screening, medical history), and if medication is clinically appropriate, you e-prescribe it to their pharmacy. Done.

What happens after 2025? The DEA is expected to finalize permanent rules — likely requiring either periodic in-person visits for long-term controlled substance patients or a special telemedicine DEA registration. For now, though, you have a clear path to treat insomnia remotely with full prescribing authority (within your scope of practice).

State Licensure: You Must Be Licensed Where the Patient Is Located

This is non-negotiable: you need an active license in the state where your patient is physically located during the telehealth visit. Telemedicine doesn’t bypass state licensing.

Some states have made this easier:

• Florida allows out-of-state providers to register as telehealth providers without full Florida licensure (you maintain your home state license and register with Florida’s Department of Health)
• Texas recently passed HB 1052 (effective January 2026) requiring insurers to cover telehealth from out-of-state providers — though you still need a Texas license

For psychiatrists, the Interstate Medical Licensure Compact (IMLC) makes obtaining multiple state licenses faster. Texas and Illinois are IMLC states; California, New York, and Florida are not (Pennsylvania joined but isn’t issuing compact licenses yet as of 2026).

PMHNPs currently must obtain individual state APRN licenses — though an APRN Compact is coming (not yet active in 2026).

The PDMP Requirement: Non-Negotiable for Controlled Substances

Nearly every state requires you to check the Prescription Drug Monitoring Program (PDMP) before prescribing controlled substances. For insomnia patients, this means:

• Checking for overlapping benzodiazepine or hypnotic prescriptions from other providers
• Screening for ‘doctor shopping’ behavior
• Documenting that you reviewed the PDMP in your chart notes

Texas, New York, Illinois, California, and Florida all mandate PDMP checks for controlled substance prescriptions. If you’re practicing across multiple states via telehealth, you’ll need access to each state’s PDMP system (or proxy arrangements).

This is administratively tedious but critical for compliance and patient safety.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Scope of Practice: Where Psychiatrists and PMHNPs Differ

Psychiatrists: Full Authority Everywhere

If you’re a psychiatrist (MD/DO), your scope of practice is straightforward: you can independently evaluate, diagnose, and prescribe any insomnia medication (controlled or not) in any state where you hold a license. Period.

You don’t need physician oversight. You don’t need collaborative agreements. You can prescribe Schedule II-V medications at your clinical discretion (though most insomnia meds are Schedule IV).

The only constraints are:

• Standard of care (thorough evaluation, appropriate follow-up)
• State-specific telehealth consent requirements
• PDMP checks before prescribing controlled substances
• Using DEA-compliant e-prescribing systems

For telehealth insomnia care, this means you can manage patients end-to-end: initial video consultation, diagnose insomnia (ruling out sleep apnea or other causes), prescribe medication, schedule follow-ups, and adjust treatment — all remotely.

PMHNPs: It Depends Entirely on Your State

Here’s where it gets complicated. Your prescribing authority as a PMHNP varies dramatically by state — and this directly affects your ability to treat insomnia via telehealth.

States fall into three categories:

1. Full Practice States (Best for NP Independence)

In these states, experienced PMHNPs can practice and prescribe completely independently — no physician oversight required.

New York: After 3,600 practice hours (~2 years full-time), you can practice without a collaborative agreement. You can prescribe all controlled substances (including Schedule IV insomnia meds) independently. Before 3,600 hours, you need a written collaboration agreement with a physician.

Illinois: After 4,000 practice hours plus 250 CE hours in your specialty, you can obtain Full Practice Authority and prescribe independently (including controlled substances). Until then, you need a collaborative agreement.

California: AB 890 created a pathway to independent practice. As a ‘103 NP’ (starting 2023), you practice in a group setting with a physician on-site. After 3 years, you can become a ‘104 NP’ with full independent practice within your certified specialty (psychiatry). By 2026, experienced psych NPs in California can essentially function like psychiatrists.

In these states, once you meet the experience requirements, you can join a telehealth platform and treat insomnia patients exactly like a psychiatrist would — no supervisory hassles.

2. Reduced Practice States (Collaboration Required)

These states require some level of physician collaboration but it’s usually not day-to-day supervision.

Early-career NPs in New York and Illinois fall into this category — you need a written collaborative agreement that outlines prescribing protocols and consultation arrangements, but the physician doesn’t need to see every patient or sign off on every prescription.

For telehealth platforms, this means the company may need to provide or help you secure a collaborating physician in that state.

3. Restricted Practice States (Significant Physician Oversight)

These states impose the most limitations. Texas, Florida, and Pennsylvania fall here.

Texas:

• You must have a Prescriptive Authority Agreement with a Texas physician
• The agreement requires monthly quality assurance meetings and periodic chart reviews
• A physician can supervise up to 7 NPs/PAs
• You cannot prescribe Schedule II drugs in outpatient settings (hospital/hospice only)
• For insomnia: You can prescribe Schedule IV meds (Ambien, Lunesta) under delegation, but you need that supervising physician relationship in place

Florida:

• Florida’s ‘autonomous NP’ law specifically excludes psychiatric NPs — you need physician supervision
• Controlled substance limits: 7-day supply maximum for Schedule II prescriptions
• Only psychiatric NPs can prescribe psychiatric controlled substances to minors
• For insomnia: You can prescribe Schedule IV hypnotics under a physician protocol, but you need that supervision agreement filed with the Board of Nursing

Pennsylvania:

• Requires a collaborative agreement with at minimum two physicians (yes, two)
• Maximum 30-day supply of Schedule II, 90-day supply of Schedule III/IV without physician re-evaluation
• For insomnia: You could prescribe 3 months of Ambien, then the patient needs physician consultation for continuation

The Bottom Line for PMHNPs: In restricted states, you’ll need a telehealth platform or employer that provides supervisory physician arrangements. This adds administrative complexity and potentially limits your autonomy — but platforms like Klarity handle these collaborations so you can focus on patient care.

State-by-State Breakdown: Priority States for Telehealth Insomnia Care

California: Progressive and Growing

NP Scope: AB 890 pathway to independence (103 NP → 104 NP after 3 years). By 2026, many experienced psych NPs practice independently.

Telehealth: Strong parity laws. Private insurers must cover telehealth equivalently to in-person visits. Tech-savvy patient population.

Market: High demand. Severe psychiatrist shortage in Central Valley, Inland Empire, and rural areas. Large employer-sponsored mental health benefits (tech companies, etc.).

Insomnia Practice: Access to app-based CBT-I and integrative treatments. Patients receptive to telehealth. Must check CURES (PDMP) every 4 months for ongoing controlled Rx.

Texas: High Demand, More Restrictions for NPs

NP Scope: Restricted practice. Need physician delegation for all prescribing. Monthly quality meetings required. Cannot prescribe Schedule II outpatient.

Telehealth: HB 1052 (Jan 2026) requires insurers to cover out-of-state telehealth (but you still need TX license). IMLC member for physicians.

Market: Massive rural need (West Texas, Panhandle). Major metros (Houston, Dallas, Austin) have growing demand. Post-pandemic telehealth acceptance is high.

Insomnia Practice: For NPs, securing a supervising physician is essential. Psychiatrists have full autonomy. Large underserved populations drive patient volume.

Florida: Complex NP Rules, High Need

NP Scope: Restricted. Psychiatric NPs excluded from autonomous practice law. Need physician supervision. 7-day Schedule II limit.

Telehealth: Out-of-state provider registration available. Schedule II prescribing via telehealth allowed for psychiatric use.

Market: Large elderly population with high insomnia prevalence. Bilingual providers (especially Spanish) in high demand. South Florida has many cash-based psychiatrists; telehealth can capture insured patients.

Insomnia Practice: Must have supervising physician agreement. Large access gap means quick patient acquisition. Elderly patients require careful hypnotic prescribing (fall risk).

New York: Experienced NPs Have Full Authority

NP Scope: After 3,600 hours, full independent practice. Before that, need collaboration agreement.

Telehealth: Strong coverage mandates. Payment approaching parity with many insurers. Medicaid covers audio-only for mental health.

Market: NYC tech-savvy population; upstate rural areas underserved. High telehealth adoption.

Insomnia Practice: I-STOP PDMP check mandatory for every controlled Rx (strictly enforced). Experienced NPs function like psychiatrists. Coordination with sleep specialists common for complex cases.

Pennsylvania: Most Restrictive for NPs

NP Scope: Requires 2-physician collaboration. 90-day maximum on Schedule III/IV without physician re-evaluation.

Telehealth: No comprehensive parity law yet. Coverage varies by insurer. IMLC member for physicians.

Market: 500,000+ residents in mental health shortage areas. High rural need (central/northern PA).

Insomnia Practice: NPs need robust physician collaboration for ongoing controlled Rx management. Psychiatrists face no restrictions. High demand but administrative complexity for NPs.

Illinois: NP-Friendly with Clear FPA Pathway

NP Scope: FPA available after 4,000 hours + 250 CE. Until then, collaborative agreement required.

Telehealth: Payment parity by law (permanent as of 2021). Strong Medicaid telehealth coverage.

Market: Chicago well-served; downstate and rural areas (Peoria, Rockford, southern IL) have major shortages.

Insomnia Practice: Clear pathway for NPs to practice independently. Psychiatrists have full authority. Supportive regulatory environment makes scaling easier.

The Economics of Telehealth Insomnia Practice: What You’ll Actually Make

The Reimbursement Reality

Insomnia medication management visits are typically 15-30 minutes and billed using E/M codes:

CPT 99213 (20-minute established patient visit): ~$95 average Medicare reimbursement
CPT 99214 (30-minute visit): ~$125 average Medicare reimbursement

Private insurance often matches or exceeds Medicare rates. With telehealth parity laws in 24+ states (including CA, NY, IL), you’re paid the same for virtual visits as in-person — no financial penalty for practicing remotely.

Typical follow-up schedule for insomnia:

• Initial visit (30 min): $125
• 2-week check-in (20 min): $95
• Monthly follow-ups (15-20 min): $95

For a patient you see monthly for insomnia management, you’re generating $95-125 per visit with minimal overhead (no office rent, no commute).

The Patient Acquisition Problem (And Why It’s Expensive)

Here’s what most providers don’t realize: acquiring a qualified psychiatric patient through traditional marketing is brutally expensive when you factor in ALL costs.

The Reality of DIY Marketing:

SEO (Search Engine Optimization):

• Costs: $2,000-5,000/month for agency + content creation
• Timeline: 6-12 months before meaningful traffic
• Conversion: Even with traffic, most visitors don’t book
• Reality: You’re burning $12,000-60,000 before seeing ROI

Google Ads:

• Cost per click: $15-40+ for mental health keywords
• Conversion rate: 2-5% (most clicks don’t book)
• Cost per booked patient: $200-400+ typically
• Reality: A $3,000/month ad budget might yield 7-15 new patients (if you’re good at it)

Directory Listings (Psychology Today, Zocdoc):

• Monthly fees: $30-100/month per directory
• Zocdoc booking fees: $35-100+ per new patient
• Competition: You’re one listing among hundreds on the same page
• Reality: Total monthly cost including subscriptions adds up quickly

Staff Time:

• Handling inbound leads (many unqualified)
• Phone/email follow-up to schedule
• No-show rates from cold leads (20-30%+)
• Reality: Hidden labor costs that most providers don’t calculate

When you add it all up: Most solo providers spend $200-500+ per acquired patient when factoring in agency fees, ad spend, testing/optimization, staff time, and no-shows. And that’s IF you have the expertise to run effective campaigns — most providers don’t.

The Platform Model Changes Everything

Klarity Health uses a pay-per-appointment model — you pay a standard listing fee when a qualified patient books with you. That’s it.

Why this makes economic sense:

✅ No upfront marketing spend — zero risk
✅ Pre-qualified patients — already matched to your specialty and availability
✅ No wasted ad spend — you only pay when patients actually book
✅ Built-in telehealth infrastructure — no separate platform costs
✅ Both insurance and cash-pay patient flow
✅ You control your schedule — only see patients when you want

The Math:

Instead of gambling $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient shows up. That’s guaranteed ROI vs. marketing roulette.

Could you eventually build a cost-effective DIY marketing system? Sure — if you have the budget, expertise, and patience to invest 6-12 months before seeing results. For most providers (especially those starting out or scaling), a platform that handles patient acquisition removes all that risk.

What Insomnia Treatment Actually Looks Like via Telehealth

Initial Consultation (30 minutes)

Your evaluation includes:

• Sleep history (onset, duration, frequency of insomnia)
• Sleep hygiene assessment (bedroom environment, pre-bed routine)
• Psychiatric screening (depression, anxiety often co-occur)
• Medical history (sleep apnea risk, restless legs, medications)
• Prior treatments tried (OTC sleep aids, CBT-I, previous prescriptions)

Many platforms provide:

• Pre-visit sleep questionnaires (Insomnia Severity Index, Pittsburgh Sleep Quality Index)
• Two-week sleep diary data from patients
• Automated screening for contraindications

You conduct this via secure video, just like an in-person appointment. You can often observe bedroom environment (lighting, screen use) during the visit — sometimes clinically useful.

Treatment Planning

Medication options for insomnia:

Non-controlled alternatives (often first-line):

• Trazodone (50-100mg)
• Mirtazapine (7.5-15mg)
• Low-dose doxepin (3-6mg)
• Melatonin (extended-release)

Controlled substances (Schedule IV):

• Zolpidem (Ambien) – 5-10mg
• Eszopiclone (Lunesta) – 1-3mg
• Zaleplon (Sonata) – 5-10mg
• Temazepam (Restoril) – 7.5-30mg

Newer non-controlled options:

• Suvorexant (Belsomra) – orexin receptor antagonist
• Lemborexant (Dayvigo)

Your clinical decision tree:

1. Rule out sleep apnea (if high suspicion, refer for sleep study)
2. Address underlying psychiatric conditions (treat depression/anxiety first if severe)
3. Start behavioral interventions (sleep hygiene, stimulus control)
4. If medication needed, prefer non-controlled options initially
5. Use controlled substances for short-term improvement while establishing behavioral changes

Follow-Up Schedule

2-week check-in (20 minutes):

• Review efficacy: Sleep latency improved? Total sleep time? Morning grogginess?
• Side effects: Next-day sedation, tolerance developing, unusual behaviors (sleep-walking)?
• Adjustment: Dose titration, switch medications, or discontinue if behavioral interventions working

Monthly medication management (15-20 minutes):

• Assess ongoing need for medication
• Monitor for tolerance/dependence (especially with benzodiazepines or Z-drugs)
• Coordinate with therapy (CBT-I referrals if not already done)
• Plan for gradual tapering when sleep stabilizes

The chronic insomnia challenge: Unlike treating depression where medication is often long-term first-line, insomnia guidelines urge caution with chronic pharmacotherapy. You’re balancing efficacy against tolerance/dependence risk, which requires careful monitoring — telehealth actually facilitates this with frequent short check-ins patients can do from home.

Documentation and Compliance

For each visit, you document:

• Telehealth consent (patient agrees to virtual care)
• Patient location (for licensing compliance)
• PDMP check (for controlled substance prescriptions)
• Clinical assessment and medical necessity for medication
• Discussion of risks/benefits
• Treatment plan and follow-up schedule

Billing: You bill the same E/M codes (99213, 99214) as in-person visits. Most insurers reimburse at parity in states with telehealth parity laws.

Why Klarity Health Makes Sense for Insomnia-Focused Providers

The Patient Acquisition Advantage

Traditional route:

• Build website ($2,000-10,000)
• SEO strategy (6-12 months, $2,000-5,000/month)
• Google Ads ($3,000-5,000/month with uncertain conversion)
• Psychology Today listing ($30-100/month, fierce competition)
• Zocdoc ($35-100 per booking + monthly fee)
• Staff time handling leads and no-shows

Total monthly investment: $5,000-10,000 before you see meaningful patient volume. And most providers lack the marketing expertise to make this work.

Klarity route:

• Zero upfront costs
• Pre-qualified patients matched to your availability
• Standard per-appointment fee
• Only pay when patients actually book

You’re essentially outsourcing patient acquisition risk. Instead of betting thousands per month on marketing channels you may not understand, you pay a known cost when a patient shows up ready to see you.

Built-In Telehealth Infrastructure

What Klarity provides:

• HIPAA-compliant video platform
• E-prescribing integrated with state PDMPs
• EHR with templates for psychiatric documentation
• Automated appointment scheduling
• Patient intake and screening forms
• Insurance credentialing support

What you don’t need:

• Separate telehealth subscription ($50-300/month)
• E-prescribing software ($100-200/month)
• Practice management system ($100-500/month)
• IT support for troubleshooting

Flexibility and Control

You set:

• Your schedule (full-time, part-time, evenings/weekends only)
• Your patient load (see 5 patients/week or 40)
• Your geographic reach (licensed in multiple states? Great — see patients across all of them)

This works for:

• New graduates building a practice without startup capital
• Established providers adding telehealth income without overhead
• Parents/caregivers needing flexible scheduling
• Providers in rural areas accessing urban patient populations

Both Insurance and Cash-Pay Patients

Klarity works with major insurance networks AND offers cash-pay options. You’re not limited to one payer type.

Why this matters:

• Insurance patients = stable, recurring revenue
• Cash-pay patients = higher per-visit income, no claims hassles
• You get both without needing separate marketing strategies

FAQ: Telehealth Insomnia Prescribing

Can I prescribe Ambien (zolpidem) to a new patient I’ve never met in person?

Yes — federal DEA flexibilities currently allow prescribing Schedule IV controlled substances (including zolpidem) via telehealth without a prior in-person visit through at least December 31, 2025. You conduct a thorough video evaluation, document appropriately, check your state PDMP, and e-prescribe as you would in-person.

What states allow PMHNPs to prescribe insomnia medications independently?

Full independent prescribing (no physician oversight): California (after 3-year transition), New York (after 3,600 hours), Illinois (after 4,000 hours + CE), and about 27 total states with full NP practice authority.

Requires physician collaboration: Texas, Florida, Pennsylvania, and most other states for newer NPs or where laws haven’t changed.

Check your state board of nursing for current requirements.

Do I need to check the PDMP every time I prescribe a sleep medication?

Usually yes — most states require PDMP checks for Schedule II-IV controlled substance prescriptions. For insomnia meds like Ambien, Lunesta, or temazepam (all Schedule IV), you’ll need to check the PDMP at least before the initial prescription and periodically for refills (some states require checks every time).

Non-controlled insomnia meds (trazodone, doxepin, mirtazapine) don’t require PDMP checks.

How do I bill insomnia medication management visits?

Standard E/M codes:

• 99213 (20-minute established patient visit): ~$95
• 99214 (30-minute visit): ~$125
• Initial visits might use 99203/99204 (new patient codes)

If you also provide therapy: You can add psychotherapy codes (90833, 90836) when combining med management with talk therapy — but document time separately and ensure medical necessity.

What’s the difference between treating insomnia and treating depression via telehealth?

Clinical differences:

• Depression: Medication is often long-term first-line (SSRIs, SNRIs). Follow-ups every 4-8 weeks once stable.
• Insomnia: Behavioral therapy (CBT-I) is first-line per guidelines. Medication typically short-term or intermittent. More frequent follow-ups initially (2-4 weeks) to monitor tolerance and taper plans.

Prescribing differences:

• Depression: Mostly non-controlled meds. Less regulatory scrutiny.
• Insomnia: Often involves controlled substances. PDMP checks required. More documentation around long-term use justification.

Telehealth differences:

• Both very feasible remotely. Insomnia might occasionally require in-person sleep studies (if suspecting apnea) — you’d coordinate referrals but the medication management stays telehealth.

What happens if DEA rules change after 2025?

Current expectation: DEA will likely require either periodic in-person visits (possibly annually) for patients on long-term controlled substances OR a special telemedicine DEA registration.

Impact on your practice: You might need to coordinate local in-person appointments for long-term insomnia patients (like annual physicals) or adjust to new registration requirements. Telehealth platforms will likely facilitate this — either by partnering with local clinics or adjusting workflows.

For short-term insomnia treatment (the ideal), this wouldn’t affect you much since you’re tapering patients off meds within weeks to months.

Can I treat insomnia patients across multiple states?

Yes, if you’re licensed in those states. Each state requires a separate license (for now — physician compacts and a future NP compact will help).

Practical consideration: Managing multiple state PDMP logins and varying controlled substance rules adds administrative burden. Telehealth platforms often provide support for multi-state compliance, but you’re ultimately responsible for knowing each state’s rules.

The Bottom Line: Why Smart Providers Choose Platforms Over DIY

Building a telehealth practice from scratch isn’t impossible — but it’s expensive, slow, and risky.

The Reality:

• 6-12 months before SEO generates meaningful patients
• $3,000-5,000/month in marketing spend (minimum)
• $200-500+ cost per acquired patient when you factor in all costs
• Steep learning curve if you’re not a marketer
• Opportunity cost (time spent on marketing = time not seeing patients)

The Platform Model:

• Zero upfront investment
• Immediate patient flow
• Predictable economics (pay per appointment)
• You focus on clinical work, not marketing

For psychiatrists and PMHNPs who want to get paid to practice medicine rather than gamble on marketing, joining a platform like Klarity Health is the smart economic choice.

You’re not sacrificing autonomy — you control your schedule, your treatment decisions, and your patient load. You’re just outsourcing the expensive, uncertain, time-consuming work of patient acquisition to a company that does it professionally at scale.

Ready to start seeing insomnia patients via telehealth without the marketing headaches?

[Explore Klarity’s provider network →]

References

1. California Board of Registered Nursing – AB 890 Implementation: Details on 103/104 NP categories and independent practice pathway (2023-2026). Available at: https://www.rn.ca.gov/practice/ab890.shtml (Updated 2024)

2. Texas Medical Board – APRN Prescribing and Supervision FAQs: Texas prescriptive authority requirements, monthly quality meetings, and Schedule II restrictions. Available at: https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision (Accessed February 2026)

3. Rivkin Rounds Law Blog – New York NP Independence Law: Analysis of NY’s 2022 legislation allowing experienced NPs (3,600+ hours) to practice without collaborative agreements. Available at: https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/ (April 13, 2022)

4. Center for Connected Health Policy (CCHP) – State Telehealth Laws Fall 2025: Comprehensive 50-state analysis of telehealth parity laws, reimbursement policies, and coverage requirements. Available at: https://www.cchpca.org/resources/state-telehealth-laws-and-reimbursement-policies-report-fall-2025/ (October 2025)

5. Commonwealth Foundation – Pennsylvania Nurse Practitioner Reform Report: Details PA’s restrictive NP practice requirements including 2-physician collaboration and 30/90-day controlled substance limits. Available at: https://commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania/ (December 5, 2022)

Note: All regulatory information verified against official statutes and state board rules as of February 26, 2026. Federal DEA telemedicine prescribing flexibilities confirmed through December 31, 2025 with anticipated extension or permanent rulemaking. Providers should verify current state board requirements as scope of practice laws continue to evolve.

Source:

• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=physician
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=Do%20I%20need%20to%20have,to%20a%20prescriptive%20authority%20agreement
• https://commonwealthfoundation.org/research/nurse-practitioner-reform-full-practice-authority-pennsylvania/#:~:text=expansive%20prescriptive%20authority%20is%20essential,survey%20of%20members%20of%20the
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/#:~:text=With%20sufficient%20experience%2C%20however%2C%20CNPs,250%20additional%20continuing%20education%20units
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=In%20September%202020%2C%20Governor%20Gavin,Chapter%20481%2C%20Statutes%20of%202024
• https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision#:~:text=match%20at%20L153%20For%20a,meetings%20must%20at%20a%20minimum
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=%E2%80%9CUnder%20HB%20607%2C%20psychiatric,%E2%80%9D
• https://usadocnetwork.com/how-to-get-insomnia-prescriptions-via-telemedicine-3#:~:text=Recent%20regulatory%20updates%20have%20introduced,evaluations%20until%20December%2031%2C%202025